Trump’s Tariff Threat Spotlights Drugmakers’ US Factory Progress

President Donald Trump’s plan to impose a 100% tariff on branded and patented drugs could sharply raise costs for pharmaceutical companies without US manufacturing capacity, raising pressure on firms that have yet to break ground....

Redirecting to full article...